Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells
Dimitrios Tzachanis(Dana-Farber Cancer Institute), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), André A. F. L. van Puijenbroek(Harvard University), Naoto Hirano(University Health Network), Michael W. Delfs, L M Nadler(Dana-Farber Cancer Institute), Gordon J. Freeman(Harvard University), Alla Berezovskaya(Ontario Institute for Cancer Research)
Cited by 277
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
The complex role of tumor-infiltrating macrophages
|Nature Immunology|2022|859